AFRINOL Drug Patent Profile
When do Afrinol patents expire, and when can generic versions of Afrinol launch?
Afrinol is a drug marketed by Schering Plough and is included in one NDA.
The generic ingredient in AFRINOL is pseudoephedrine sulfate. There is one drug master file entry for this compound. Additional details are available on the pseudoephedrine sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AFRINOL?
- What are the global sales for AFRINOL?
- What is Average Wholesale Price for AFRINOL?
Summary for AFRINOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 719 |
| DailyMed Link: | AFRINOL at DailyMed |
US Patents and Regulatory Information for AFRINOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering Plough | AFRINOL | pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018191-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
